Radhakrishnan Pillai Selected Research

halobetasol (ulobetasol)

6/2021	Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology.
6/2019	A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis.
3/2019	Efficacy of a Once-Daily Fixed Combination Halobetasol (0.01%) and Tazarotene (0.045%) Lotion in the Treatment of Localized Moderate-to-Severe Plaque Psoriasis
3/2019	Assessing the Synergistic Effect of a Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion in Moderate-to-Severe Plaque Psoriasis
1/2019	Long-term safety results from a phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis.
1/2019	Safety and efficacy of halobetasol propionate lotion 0.01% in the treatment of moderate to severe plaque psoriasis: a pooled analysis of 2 phase 3 studies.
1/2019	Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential.
12/2018	Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque Psoriasis
11/2018	Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% Cream.
10/2018	Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled Trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Radhakrishnan Pillai Research Topics

Disease

18	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2021 - 01/2017
15	Acne Vulgaris 09/2022 - 08/2013
15	Onychomycosis (Tinea Unguium) 04/2021 - 02/2013
9	Erythema 03/2020 - 10/2014
5	Infections 08/2015 - 07/2014
4	Mycoses (Diseases, Fungus) 01/2016 - 04/2013
2	Pain (Aches) 01/2020 - 06/2019
1	Overweight 09/2022
1	Chronic Disease (Chronic Diseases) 08/2018
1	Mental Disorders (Mental Disorder) 01/2018
1	Pruritus (Itching) 06/2016
1	Tinea Pedis (Athlete's Foot) 01/2016
1	Necrosis 10/2014
1	Inflammation (Inflammations) 10/2014
1	Urologic Diseases (Urinary Tract Disease) 10/2014
1	Atrophy 02/2006
1	Telangiectasis (Telangiectasia) 02/2006

Drug/Important Bio-Agent (IBA)

19	tazarotene (Tazorac)FDA Link 09/2022 - 03/2017
15	halobetasol (ulobetasol)FDA LinkGeneric 06/2021 - 03/2017
15	efinaconazoleIBA 04/2021 - 02/2013
13	SolutionsIBA 04/2021 - 02/2013
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 02/2006
6	Immunoglobulin A (IgA)IBA 03/2019 - 03/2017
6	TriazolesIBA 10/2014 - 02/2013
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2022 - 10/2018
5	Pharmaceutical PreparationsIBA 01/2016 - 09/2013
3	Benzoyl Peroxide FDA LinkGeneric 01/2022 - 08/2013
3	EmulsionsIBA 01/2020 - 06/2019
3	brodalumabIBA 12/2019 - 01/2017
3	Antifungal AgentsIBA 11/2014 - 04/2013
2	Adapalene (Differin)FDA LinkGeneric 01/2022 - 06/2016
2	RetinoidsIBA 01/2022 - 01/2020
2	Monoclonal AntibodiesIBA 12/2019 - 01/2018
2	Therapeutic UsesIBA 07/2018 - 07/2015
2	Clindamycin (Cleocin)FDA LinkGeneric 06/2016 - 09/2015
2	Terbinafine (Lamisil)FDA LinkGeneric 01/2016 - 04/2013
2	Ciclopirox (Loprox)FDA LinkGeneric 07/2014 - 04/2013
2	amorolfineIBA 07/2014 - 04/2013
1	clindamycin phosphate (Clindets)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Drug CombinationsIBA 01/2022
1	GelsIBA 01/2022
1	Interleukin-17 ReceptorsIBA 01/2018
1	luliconazoleIBA 01/2016
1	Fluorescein (Funduscein)FDA LinkGeneric 08/2015
1	antineoplaston A10 (A 10)IBA 10/2014
1	AzolesIBA 10/2014
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 10/2014
1	Keratins (Keratin)IBA 07/2014
1	Itraconazole (Sporanox)FDA LinkGeneric 04/2013
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 02/2006
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2006

Therapy/Procedure

10	Therapeutics 03/2019 - 08/2013
1	Subcutaneous Injections 10/2014
1	Topical Administration 09/2013